These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3264141)

  • 1. Clastogenic factor in ischemia-reperfusion injury during open-heart surgery: protective effect of allopurinol.
    Emerit I; Fabiani JN; Ponzio O; Murday A; Lunel F; Carpentier A
    Ann Thorac Surg; 1988 Dec; 46(6):619-24. PubMed ID: 3264141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clastogenic factor in ischemia-reperfusion injury: protective effect of allopurinol.
    Emerit I; Fabiani JN
    Basic Life Sci; 1988; 49():863-7. PubMed ID: 3266923
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosomal aberrations and neutrophil activation induced by reperfusion in the ischaemic human heart.
    Fabiani JN; Farah B; Vuilleminot A; Lecompte T; Emerit I; Chardigny C; Carpentier A
    Eur Heart J; 1993 Nov; 14 Suppl G():12-7. PubMed ID: 8287864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting.
    Sawa Y; Matsuda H; Shimazaki Y; Kaneko M; Nishimura M; Amemiya A; Sakai K; Nakano S
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1125-31. PubMed ID: 7983882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery.
    Castelli P; Condemi AM; Brambillasca C; Fundarò P; Botta M; Lemma M; Vanelli P; Santoli C; Gatti S; Riva E
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):119-25. PubMed ID: 7723340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting.
    Coghlan JG; Flitter WD; Clutton SM; Panda R; Daly R; Wright G; Ilsley CD; Slater TF
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):248-56. PubMed ID: 8283893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals and cardioplegia: the absence of an additive effect with allopurinol pretreatment and the use of antioxidant enzymes in the rat.
    Chambers DJ; Braimbridge MV; Hearse DJ
    Eur J Cardiothorac Surg; 1987; 1(2):80-90. PubMed ID: 2856611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of allopurinol for prevention of myocardial reperfusion injury in open heart surgery].
    Yamazaki I; Soma T; Ichikawa Y; Iwai Y; Kondo J; Matsumoto A
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Jan; 43(1):26-31. PubMed ID: 7884257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of free radical-induced myocardial reperfusion injury with allopurinol.
    Stewart JR; Crute SL; Loughlin V; Hess ML; Greenfield LJ
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):68-72. PubMed ID: 2989620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of allopurinol in coronary bypass surgery.
    Johnson WD; Kayser KL; Brenowitz JB; Saedi SF
    Am Heart J; 1991 Jan; 121(1 Pt 1):20-4. PubMed ID: 1985364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of allopurinol on myocardial oxygen free radical production in coronary bypass surgery.
    Tarkka MR; Vuolle M; Kaukinen S; Holm P; Eloranta J; Kaukinen U; Sisto T; Kataja J
    Scand Cardiovasc J; 2000 Dec; 34(6):593-6. PubMed ID: 11214014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol improves myocardial reperfusion injury in a xanthine oxidase-free model.
    Hopson SB; Lust RM; Sun YS; Zeri RS; Morrison RF; Otaki M; Chitwood WR
    J Natl Med Assoc; 1995 Jul; 87(7):480-4. PubMed ID: 7636893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial protection from ischemic and reperfusion injuries in reconstructive heart surgery].
    Trekova NA; Iavorovskiĭ AG; Belous AE; Dement'eva II; Flerov EV; Shishlo LA
    Anesteziol Reanimatol; 1995; (2):8-14. PubMed ID: 7645783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of free radical-induced myocardial injury by allopurinol. Experimental study in cardiac preservation and transplantation.
    Bando K; Tago M; Teramoto S
    J Thorac Cardiovasc Surg; 1988 Mar; 95(3):465-73. PubMed ID: 3278169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin.
    Kalweit GA; Schipke JD; Godehardt E; Gams E
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):1011-8. PubMed ID: 11689808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest.
    Chambers DJ; Braimbridge MV; Hearse DJ
    Ann Thorac Surg; 1987 Sep; 44(3):291-7. PubMed ID: 3632115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of allopurinol on free oxygen radicals in myocardial reperfusion.
    Fabián J; Popovic Z; Vucinic M
    Cor Vasa; 1992; 34(5-6):411-20. PubMed ID: 1339712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between allopurinol and copper: possible role in myocardial protection.
    Malkiel S; Har-el R; Schwalb H; Uretzky G; Borman JB; Chevion M
    Free Radic Res Commun; 1993; 18(1):7-15. PubMed ID: 8349148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of leukocyte reduction filters on inflammatory mediator release during coronary artery bypass grafting.
    Bartkowiak M; Bugajski P; Siminiak T; Kalawski R
    Kardiol Pol; 2013; 71(9):945-50. PubMed ID: 24065423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.